PExA Valuation Multiples

PExA Overview

About PExA

PExA AB develops, manufactures, and markets a research tool for studying respiratory diseases, including asthma and chronic obstructive pulmonary disease (COPD). Its product includes PExA 2.0.

Founded

2004

HQ

Employees

3

Website

pexa.se

Sectors

Medical DevicesHealthTech

Financials (FY)

Revenue: $52K

EBITDA: ($643K)

EV

$2M

Valuation Multiples

Multiples.vc

Start free trial

PExA Financials

PExA reported last fiscal year revenue of $52K and negative EBITDA of ($643K).

In the same fiscal year, PExA generated $326K in gross profit, ($643K) in EBITDA losses, and had net loss of ($682K).

PExA P&L

In the most recent fiscal year, PExA reported revenue of $52K and EBITDA of ($643K).

PExA expects next 12-month revenue of XXX and NTM EBITDA of XXX

PExA Stock Performance

PExA has current market cap of $3M, and enterprise value of $2M.

PExA's stock price is $0.03.

PExA Valuation Multiples

PExA trades at 47.0x EV/Revenue multiple, and (3.8x) EV/EBITDA.

PExA Financial Valuation Multiples

As of April 20, 2026, PExA has market cap of $3M and EV of $2M.

Equity research analysts estimate PExA's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

PExA has a P/E ratio of (4.6x).

PExA Margins & Growth Rates

PExA's revenue in the last fiscal year declined by (34%).

PExA's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.3M for the same period.

PExA Public Comps

See public comps and valuation multiples for other Medical Devices comps.

PExA M&A Activity

PExA acquired XXX companies to date.

Last acquisition by PExA was on XXXXXXXX, XXXXX. PExA acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

PExA Investment Activity

PExA invested in XXX companies to date.

PExA made its latest investment on XXXXXXXX, XXXXX. PExA invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).